Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct-Dec;20(4):2727.
doi: 10.18549/PharmPract.2022.4.2727. Epub 2022 Sep 8.

Double blind randomized controlled trial for subjects undergoing surgery receiving surgical antimicrobial prophylaxis at tertiary hospital: the clinical pharmacist's interventions

Asim Ahmed Elnour  1 , Israa Y Al-Khidir  2 , Habab Elkheir  3 , Abdalla Elkhawad  4 , Ahmed A Mohammed O  5 , Al-Kubaissi Khalid A  6 , Ghadah Nahar  7 , Shahad Fayad Alrwili  8 , Donia Ahmed Alshelaly  9 , Amjad Saleh  10 , Latefa Khulif Aljaber  11 , Abrar Ayad Alrashedi  12
Affiliations

Double blind randomized controlled trial for subjects undergoing surgery receiving surgical antimicrobial prophylaxis at tertiary hospital: the clinical pharmacist's interventions

Asim Ahmed Elnour et al. Pharm Pract (Granada). 2022 Oct-Dec.

Abstract

Background: A surgical site infection (SSI) has significant clinical, humanistic and economic consequences. Surgical antimicrobials prophylaxis (SAP) is a reliable standard to prevent SSIs.

Objective: The objective was to test that the clinical pharmacist's interventions may facilitate the implementation of SAP protocol and subsequent reduction of SSIs.

Methods: This was double blinded randomized controlled interventional hospital-based-study at Khartoum State-Sudan. A total of 226 subjects underwent general surgeries at four surgical units. Subjects were randomized to interventions and controls in a (1:1) ratio where patient, assessors and physician were blinded. The surgical team has received structured educational and behavioral SAP protocol mini courses by way of directed lecturers, workshops, seminars and awareness campaigns delivered by the clinical pharmacist. The clinical pharmacist provided SAP protocol to the interventions group. The outcome measure was the primary reduction in SSIs.

Results: There were (51.8%, 117/226) females, (61/113 interventions versus 56/113 controls), and (48.2%, 109/226) males (52 interventions and 57 controls). The overall rate of SSIs was assessed during 14 days post-operatively and was documented in (35.4%, 80/226). The difference in adherence to locally developed SAP protocol regarding the recommended antimicrobial was significant (P <0.001) between the interventions group (78, 69%) and the controls group (59, 52.2%). The clinical pharmacist's implementation of the SAP protocol revealed significant differences in SSIs with reduction in SSIs from 42.5% to 25.7% versus the controls group from 57.5% to 44.2% respectively, P = 0.001 between the interventions group and the controls group respectively.

Conclusion: The clinical pharmacist's interventions were very effective in sustainable adherence to SAP protocol and subsequent reduction in SSIs within the interventions group.

Keywords: adherence; clinical pharmacist; randomized clinical trial; surgical antimicrobials prophylaxis (SAP); surgical site infections (SSIs).

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. 1. Surgical site infections:prevention and treatment. NICE Guideline, No. 125. NICE Guideline Updates Team (UK). London:National Institute for Health and Care Excellence (UK);2019. https://www.ncbi.nlm.nih.gov/books/NBK542473/. (Accessed 24th December 2019). - PubMed
    2. Surgical site infections:prevention and treatment. NICE Guideline, No 125. NICE Guideline Updates Team (UK) London: National Institute for Health and Care Excellence (UK); 2019. [Accessed 24th December 2019]. https: //www.ncbi.nlm.nih.gov/books/NBK542473/ - PubMed
    1. 2. Goede WJ, Lovely JK, Thompson RL, et al. Assessment of Prophylactic Antibiotic Use in Patients with Surgical Site Infections. Hosp Pharm. 2013;48(7):560-567. https://doi.org/10.1310/hpj4807-560 - PMC - PubMed
    2. Goede WJ, Lovely JK, Thompson RL, et al. Assessment of Prophylactic Antibiotic Use in Patients with Surgical Site Infections. Hosp Pharm. 2013;48(7):560–567. doi: 10.1310/hpj4807-560. - DOI - PMC - PubMed
    1. 3. Singh R, Singla P, Chaudhary U. Surgical site infections:classification, risk factors, pathogenesis and preventive management:review article. Int J Pharma Research Health Sci. 2014;2(3):203-214.
    2. Singh R, Singla P, Chaudhary U. Surgical site infections:classification, risk factors, pathogenesis and preventive management:review article. Int J Pharma Research Health Sci. 2014;2(3):203–214.
    1. 4. Ameh EA1, Mshelbwala PM, Nasir AA, et al. Surgical site infection in children:prospective analysis of the burden and risk factors in a sub-Saharan African setting. Surg Infect. 2009;10(2):105-109. 10.1089/sur.2007.082 - PubMed
    2. Ameh EA1, Mshelbwala PM, Nasir AA, et al. Surgical site infection in children:prospective analysis of the burden and risk factors in a sub-Saharan African setting. Surg Infect. 2009;10(2):105–109. 10.1089/sur.2007.082. - PubMed
    1. 5. Surgical Site Infection (SSI) Event:Center for Disease Control. 2010.http://www.cdc.gov/nhsn/PDFs/pscManual/9pscSSIcurrent.pdf?agree=yes&next=Ac.... Updated January 2015. Accessed May, 2018.
    2. Surgical Site Infection (SSI) Event:Center for Disease Control. 2010. [Accessed May, 2018]. https: //www.cdc.gov/nhsn/PDFs/pscManual/9pscSSIcurrent.pdf?agree=yes&next=Acce... .

LinkOut - more resources